山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (2): 26-30.doi: 10.6040/j.issn.1673-3770.1.2019.010

• 专家笔谈 • 上一篇    下一篇

鼻咽癌的综合治疗研究进展

陆海军*(),刘霁,丁晓   

  1. 青岛大学附属医院肿瘤放疗科，山东 青岛 266003
  • 收稿日期:2019-02-20 出版日期:2019-03-20 发布日期:2019-03-28
  • 通讯作者: 陆海军 E-mail:lhj82920608@163.com
  • 作者简介:陆海军，医学博士，硕士生导师，青岛大学附属医院肿瘤放疗科主任。主要学术任职：中国医师协会放射肿瘤治疗医师分会委员，中国抗癌协会肿瘤精准治疗专业委员会委员，中国抗癌协会肿瘤热疗专业委员会委员，山东省医学会肿瘤放疗专业委员会副主任委员，世界华人医师协会放疗专业委员会常务委员，中国脑胶质瘤协作组成员、胶东协作组组长，山东省医师协会肿瘤综合治疗委员会副主任委员,山东省医学会姑息医学分会青年委员会副主任委员。青岛市优秀青年医学专家。擅长鼻咽癌、肺癌、食管及胃肠道肿瘤、乳腺癌、妇科肿瘤和淋巴瘤等的精准放疗及综合治疗。发表论文50余篇，主编著作1部，参编5部，获省部级二等奖3项，三等奖4项，在研课题7项

Progress in the comprehensive treatment for nasopharyngeal carcinoma

Haijun LU*(),Ji LIU,Xiao DING   

  1. Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2019-02-20 Online:2019-03-20 Published:2019-03-28
  • Contact: Haijun LU E-mail:lhj82920608@163.com

RichHTML

43

HTML

PDF (PC)

634

摘要：

鼻咽癌是一种特殊且好发的头颈部肿瘤，好发于我国华南尤其是两广地区。因其解剖学限制及放疗敏感性，放疗为其主要的治疗手段，但单纯放疗有一定的局限性，形成了以放疗为基础，配合手术治疗、化疗、靶向治疗等的综合治疗是中晚期鼻咽癌的标准治疗模式。

关键词: 鼻咽肿瘤, 外科手术, 放射治疗, 化学治疗, 靶向治疗

Abstract:

Nasopharyngeal carcinoma is a distinct type of head and neck cancer that is common in South China, especially Guangdong and Guangxi. Because of the anatomical limitations of nasopharyngeal carcinoma and its sensitivity to radiotherapy, radiotherapy is the main treatment, although radiotherapy has certain limitations. Therefore, treatment for nasopharyngeal carcinoma includes radiotherapy combined with surgical treatment, chemotherapy, targeted therapy, and other comprehensive treatments.

Key words: Nasopharyngeal neoplasms, Surgical procedures, operative, Radiotherapy, Chemotherapy, Targeted therapy

中图分类号: 

  • R739.6
1 Al-Sarraf M , LeBlanc M , Giri PG , et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized Intergroup study 0099[J]. J Clin Oncol, 1998, 16 (4): 1310- 1317.
doi: 10.1200/JCO.1998.16.4.1310
2 Wee J , Tan EH , Tai BC , et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage Ⅲ and Ⅳ nasopharyngeal cancer of the endemic variety[J]. J Clin Oncol, 2005, 23 (27): 6730- 6738.
doi: 10.1200/JCO.2005.16.790
3 Lee AW , Tung SY , Chua DT , et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma[J]. J Natl Cancer Inst, 2010, 102 (15): 1188- 98.
doi: 10.1093/jnci/djq258
4 Bian ZM , Elner VM , Lukacs NW , et al. Glycated human serum albumin induces IL-8 and MCP-1 gene expression in human corneal keratocytes[J]. Curr Eye Res, 1998, 17 (1): 65- 72.
doi: 10.1076/ceyr.17.1.65.5253
5 Motzer RJ , Agarwal N , Beard C , et al. NCCN clinical practice guidelines in oncology: kidney cancer[J]. J Natl Compr Canc Netw, 2009, 4 (8): 350- 391.
6 Chan ATC, Gregoire V, Lefebvre JL, et al. Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Annals of Oncology, 2012, 23(suppl 7):vii83-vii85. doi:10.1093/annonc/mds266.
7 Lang JY , Gao L , Guo Y , et al. Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013[J]. Future Oncol, 2014, 10 (9): 1635- 1648.
doi: 10.2217/fon.14.44
8 Chen L , Hu CS , Chen XZ , et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial[J]. Lancet Oncol, 2012, 13 (2): 163- 171.
doi: 10.1016/S1470-2045(11)70320-5
9 Tan TH , Soon YY , Cheo T , et al. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis[J]. Radiother Oncol, 2018, 129 (1): 10- 17.
doi: 10.1016/j.radonc.2018.02.027
10 Hui EP , Ma BB , Leung SF , et al. Randomized phase Ⅱ trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma[J]. J Clin Oncol, 2009, 27 (2): 242- 249.
doi: 10.1200/JCO.2008.18.1545
11 Chen YP , Wang ZX , Chen L , et al. A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma[J]. Ann Oncol, 2015, 26 (1): 205- 211.
doi: 10.1093/annonc/mdu507
12 OuYang PY , Xie C , Mao YP , et al. Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials[J]. Ann Oncol, 2013, 24 (8): 2136- 2146.
doi: 10.1093/annonc/mdt146
13 Cao SM , Yang Q , Guo L , et al. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase Ⅲ multicentre randomised controlled trial[J]. Eur J Cancer, 2017, 75: 14- 23.
doi: 10.1016/j.ejca.2016.12.039
14 Du CR , Ying HM , Zhou JJ , et al. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Int J Clin Oncol, 2013, 18 (3): 464- 471.
doi: 10.1007/s10147-012-0403-y
15 Kong L , Zhang YW , Hu CS , et al. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage Ⅲ or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials[J]. Cancer, 2017, 123 (12): 2258- 2267.
doi: 10.1002/cncr.30566
16 Sun Y , Li WF , Chen NY , et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial[J]. Lancet Oncol, 2016, 17 (11): 1509- 1520.
doi: 10.1016/S1470-2045(16)30410-7
17 Wu MY , He XY , Hu CS . Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Medicine (Baltimore), 2018, 97 (50): e13361.
doi: 10.1097/MD.0000000000013361
18 Chen YP , Guo R , Liu N , et al. Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: a bayesian network meta-analysis of randomized controlled trials[J]. J Cancer, 2015, 6 (9): 883- 892.
doi: 10.7150/jca.11814
19 Ooft ML , Braunius WW , Heus P , et al. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis[J]. Biomark Med, 2015, 9 (10): 997- 1010.
doi: 10.2217/bmm.15.68
20 Huang JF , Yuan XP , Pang QF , et al. Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells[J]. DDDT, 2018, 12: 2223- 2231.
doi: 10.2147/dddt.s163595
21 Huang Y , Qiu QH . Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137 (11): 1194- 1198.
doi: 10.1080/00016489.2017.1351041
22 Si YF, Lan GP, Deng ZX, et al. Influence of endoscopic sinus surgery on the quality of life of patients with early nasopharyngeal carcinoma and the analysis of prognosis-related factors[J]. Tumour Biol, 2017, 39(7):1010428317707435. doi:10.1177/1010428317707435.
23 Sun J , Huang ZY , Hu ZY , et al. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database[J]. J Transl Med, 2017, 15 (1): 116.
doi: 10.1186/s12967-017-1204-x
[1] 姜彦. 鼻咽癌复发及鼻内镜外科手术的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 1-11.
[2] 陈冬平,杨致欢,张炎,方楠,齐斌. 复发鼻咽癌手术治疗地位的思考[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 12-16.
[3] 邱前辉,陈卓. 鼻内镜手术治疗首诊局部晚期鼻咽癌及放疗后严重并发症的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 17-20.
[4] 王振霖,刘俊其. 鼻咽癌外科治疗中的颈内动脉保护[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 21-25.
[5] 陈瑞,李杰恩. 鼻咽癌放疗后诱发头颈部恶性肿瘤的治疗[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 31-34.
[6] 徐文瑞,姜彦. 复发鼻咽癌挽救性手术方法研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 35-38.
[7] 刘全,孙希才,于华鹏,赵可庆,张焕康,赵卫东,顾瑜蓉,李厚勇,王德辉,余洪猛. 鼻内镜下鼻咽癌切除术的手术分型[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 39-45.
[8] 高俊潇,邱前辉. 黏膜瓣在鼻咽癌放疗后鼻内镜手术修复颅底组织缺损中的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 46-50.
[9] 赵丽娟,姜彦,于龙刚,蔡亮,陈敏,张继生,李志远,鞠建宝,李娜. 鼻咽癌内镜手术治疗临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 51-56.
[10] 孙笑晗,李娜. 西班牙医学肿瘤学会鼻咽癌临床指南(2017)介绍[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 57-59.
[11] 王俊,邢奋丽,朱萍,孙亚萍,汤翠菊. 鼻咽癌放疗期间两种鼻腔冲洗方法的应用效果比较[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 60-63.
[12] 王玥,刘芊,王海波. 自发性脑脊液耳漏的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 130-135.
[13] 余洪猛,刘琢扶,戴琪. 合并哮喘的慢性鼻-鼻窦炎的鼻内镜手术治疗[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 38-41.
[14] 齐岩,刘俊其,彭舒娅,罗凯,张名霞,王振霖. 鼻内镜下选择性翼管神经切断术对伴有变应性鼻炎的慢性鼻窦炎的疗效观察[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 109-113.
[15] 韩阳,杨小健,唐力行,王蓬鹏,张杰,葛文彤. 鼻腔鼻窦青少年型骨化纤维瘤六例临床分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 79-83.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 林彬,王挥戈 . 功能性内镜鼻窦手术后鼻黏膜纤毛转归的研究[J]. 山东大学耳鼻喉眼学报, 2006, 20(6): 481 -487 .
[2] 曹忠良 . 颌面复合伤155例临床分析[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 89 -89 .
[3] 栾建刚,梁传余,文艳君,李炯 . 抑制表皮生长因子受体基因表达的pSIREN-ShuttleRNAi表达载体的构建[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 4 -8 .
[4] 毕景云 . 鼻中隔矫正术后血肿的处理[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 90 -91 .
[5] 刘大昱,潘新良,雷大鹏,许风雷,张立强,栾信庸 . 梨状窝内侧壁癌的手术治疗[J]. 山东大学耳鼻喉眼学报, 2007, 21(1): 8 -11 .
[6] 楼正才 . 掌拳击伤鼓膜损伤机制及临床特点分析[J]. 山东大学耳鼻喉眼学报, 2008, 22(2): 188 -188 .
[7] 孟庆国,卢永田,范献良 . 杀伤细胞免疫球蛋白样受体基因多态性与鼻咽癌的关联性[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 196 -199 .
[8] 谢治年 综述,姬长友 审校 . RNA干扰及其在喉鳞癌研究中的应用[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 200 -203 .
[9] 刘强和,罗香林,耿宛平,陈 晨,雷 迅,刘芳贤,邓 明 . 快速老化小鼠的听功能和耳蜗螺旋神经元的增龄性变化[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 215 -217 .
[10] 杨淑娟,袁 英,刘付星,秦海平 . 美宝湿润烧伤膏联合蛋膜贴补治疗外伤性鼓膜穿孔40例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 227 -227 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发